Rachel Elizabeth Johns

This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent. Top assignee: Avidity Biosciences, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachel Elizabeth Johns. Retrieved from https://idiyas.com/inventor/rachel-elizabeth-johns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 140(Granted Patents)

Location History:

San Diego, CA (US) (2019 - 2020)
La Jolla, CA (US) (2021 - 2023)

Company Filing History:

10 out of 55

Avidity Biosciences, Inc.

patents

Years Active: 2019-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760113 - ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND USES THEREOF (2026-10-13),

2. 12351637 - Nucleic acid-polypeptide compositions and uses thereof (2025-07-08),

3. 12234290 - Nucleic acid-polypeptide compositions and uses thereof (2025-02-25),

4. 11834510 - Anti-transferrin receptor antibodies and uses thereof (2023-12-05),

5. 11028179 - Anti-transferrin receptor antibodies and uses thereof (2021-06-08),

6. 10913800 - Anti-transferrin receptor antibodies and uses thereof (2021-02-09),

7. 10800848 - Nucleic acid-polypeptide compositions and uses thereof (2020-10-13),

8. 10787519 - Nucleic acid-polypeptide compositions and uses thereof (2020-09-29),

9. 10550188 - Nucleic acid-polypeptide compositions and uses thereof (2020-02-04),

10. 10487149 - Nucleic acid-polypeptide compositions and uses thereof (2019-11-26),

Title: The Innovative Contributions of Rachel Elizabeth Johns

Introduction

Rachel Elizabeth Johns is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, holding a total of nine patents. Her work primarily focuses on the development of novel compositions and pharmaceutical formulations aimed at treating cancer.

Latest Patents

Among her latest patents is a groundbreaking invention related to nucleic acid-polypeptide compositions. This patent discloses compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a polynucleic acid molecule and a polymer. Additionally, it describes methods for treating cancer using these innovative compositions and formulations.

Career Highlights

Rachel is currently associated with Avidity Biosciences, Inc., where she continues to push the boundaries of scientific research and innovation. Her expertise in the field has positioned her as a key player in the development of therapeutic solutions.

Collaborations

Throughout her career, Rachel has collaborated with notable colleagues, including Venkata Ramana Doppalapudi and Beatrice Diana Darimont. These collaborations have further enhanced her research and contributed to the advancement of her projects.

Conclusion

Rachel Elizabeth Johns exemplifies the spirit of innovation in biotechnology through her extensive patent portfolio and impactful research. Her contributions are paving the way for new treatments in cancer therapy, showcasing the importance of inventors in advancing medical science.

Profile summary based on public USPTO records.